2/1
09:11 pm
brtx
?????????????????????????????2035????18?6170??????49?5700???????????????(CAGR)10.29%???????????? [CNET News]
Low
Report
?????????????????????????????2035????18?6170??????49?5700???????????????(CAGR)10.29%???????????? [CNET News]
11/25
01:48 pm
brtx
Biorestorative Therapies (NASDAQ:BRTX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Biorestorative Therapies (NASDAQ:BRTX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
07:00 am
brtx
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
Medium
Report
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
11/12
06:52 pm
brtx
BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/12
04:05 pm
brtx
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update